+/(-) +/(-)% Assets Cash, Cash equivalents and current investments 138.76 188.50 49.74 35.85% Trade and other accounts receivable 1,117.59 1,397.55 279.96 25.05% Other current assets 82.73 90.03 7.30 8.82% Advance
its revenue streams which mitigate the risk of reliance on sales in China. At present, the Company’s products are well - received in the Philippines but still could not make up for the slowdown in sales
527.68 million baht, by following reasons. Cash and cash equivalents amount of 160.96 million baht had a net increase of 91.89 million baht when compared to year 2018 had in the amount of 69.07 million
(16.20) (4.27) Current assets at Baht 102.61 million, decreased by Baht 8.83 million or equivalent to 7.93%, mainly due to decreasing of cash and cash equivalent by Baht 2 0 .1 4 million or equivalent to 3
million baht, by following reasons. 6 Cash and cash equivalents amount of 160.96 million baht had a net increase of 91.89 million baht when compared to year 2018 had in the amount of 69.07 million baht
กับ 116.1 ลานบาท เติบโตรอยละ 58.4 จากไตรมาสเดียวกันของปที่แลว ยอดจดัเก็บหนี้ (Cash Collection) เทากับ 514 ลานบาท เติบโตรอยละ 59.1 จากไตรมาสเดยีวกันของปที่แลว บริษัทสามารถจัดเก็บไดมีประ
well as medical service concerning health and esthetics. 2. Overview of operating results in the Quarter 1’2018. The global economy has continued its steady growth as a result of a tightening monetary
was cash and cash equivalents of Baht 81.65 million due to payment to account payables and for operation of the company. Total Liabilities As ended June 30, 2018, the company and its subsidiaries’ total
2018, the Company had total assets of Baht 6,774.63 million, increased by Baht 545.54 million or 8.75% from 31 December 2017 due to; 1. A decrease in cash and cash equivalent at amount of Baht 13.90
no duty to disclose the transaction under the Acquisition Notification. 6. Sources of Funding The source of funds of INBV would be from the Company’s internal cash flow and unutilized credit lines from